Application of Xinde Lu students in clinical treatment of pleural effusion / 中国生化药物杂志

ABSTRACT

Objective To investigate the effect of recombinant human interleukin-2 injection in the treatment of pleural effusion. Methods Retrospective analysis of 78 patients with pleural effusion in our hospital from April 2016 to August 2017 were treated with recombinant human interleukin-2 injection treatment and nursing data. Results After the treatment,patients had chest tightness, chest pain, fever, shortness of breath and other symptoms, and two cases of cardiotoxicity cases. Conclusion In the process of treatment of pleural effusion with recombinant human interleukin-2 injection, it should be combined with targeted care to reduce the incidence of clinical adverse reactions and cardiotoxicity, so as to improve the quality of life of patients.